statistiche ricercatore

Continente	#
AS - Asia	432
EU - Europa	349
NA - Nord America	299
SA - Sud America	48
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	24
OC - Oceania	1
Totale	1.191

Nazione	#
US - Stati Uniti d'America	280
IT - Italia	203
VN - Vietnam	127
CN - Cina	92
SG - Singapore	92
BR - Brasile	33
BD - Bangladesh	26
NL - Olanda	26
DE - Germania	25
HK - Hong Kong	25
FI - Finlandia	23
KR - Corea	23
IN - India	16
SE - Svezia	16
FR - Francia	12
CA - Canada	10
GB - Regno Unito	10
JP - Giappone	10
TG - Togo	8
IE - Irlanda	7
AT - Austria	5
CI - Costa d'Avorio	5
MX - Messico	5
PH - Filippine	5
CH - Svizzera	4
EC - Ecuador	4
PL - Polonia	4
SC - Seychelles	4
CL - Cile	3
ES - Italia	3
ID - Indonesia	3
RU - Federazione Russa	3
AR - Argentina	2
BG - Bulgaria	2
CR - Costa Rica	2
IR - Iran	2
JO - Giordania	2
NG - Nigeria	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
TW - Taiwan	2
UY - Uruguay	2
VE - Venezuela	2
BE - Belgio	1
CO - Colombia	1
EG - Egitto	1
IQ - Iraq	1
JM - Giamaica	1
LT - Lituania	1
MA - Marocco	1
MD - Moldavia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PK - Pakistan	1
PT - Portogallo	1
PY - Paraguay	1
SI - Slovenia	1
SV - El Salvador	1
TR - Turchia	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	1.154

Nome	#
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia	298
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure	204
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets	168
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction	148
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia	112
null	99
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes	63
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease	46
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5]	38
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers	15
Totale	1.191

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	56	0	0	1	4	11	4	0	1	3	6	16	10
2022/2023	96	11	17	2	9	9	7	2	8	16	1	9	5
2023/2024	60	1	9	2	5	6	10	0	5	3	9	7	3
2024/2025	197	13	17	16	13	6	15	16	9	13	23	17	39
2025/2026	695	47	62	43	33	27	32	63	32	184	61	57	54
2026/2027	82	36	39	7	0	0	0	0	0	0	0	0	0
Totale													1.191

CRIS Current Research Information System